For instance, JHU‐083 was shown to significantly suppress tumor growth in a xenograft mouse model by reducing both oxidative and glycolytic metabolism in cancer cells while simultaneously enhancing CD8+ T‐cell function [13]. This evidence concerns the gene CD8A and cancer.